Description
When a patient enters the emergency department presenting with the symptoms of a myocardial infarction (MI), every moment is critical. Achieving favorable clinical and operational outcomes requires fast and accurate chest pain assessment at the point of care, as well as coordination with the laboratory for quality assurance. Having high-sensitivity troponin testing at the point of care producing accurate results in just 8 minutes could transform care delivery for millions of people each year, improving ED throughput, reducing stress and strain on acute care clinicians, and aiding in optimizing the use of time and resources of busy laboratories.
Features & Benefits:
Simple to use and easily integrated into existing systems, the Atellica® VTLi Immunoassay Analyzer, powered by Magnotech® Technology, delivers accurate, clinically actionable high-sensitivity troponin I results directly in the hands of those who need it most.
- The Atellica® VTLi systems streamlines chest pain assessment, aiding in earlier disposition decisions for patients not having an MI and fast interventions for those who are.
- The Atellica® VTLi systems offers hs-cTnl testing right at the point of care. Results are available in just minutes for clinicians and laboratory partners.
The Atellica® VTLi systems will aid in transforming your chest pain assessment process to benefit patients, clinicians, and operational workflow.
